- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 24.04. | Pfizer's cost-cutting push reaches Ireland again as it plans manufacturing layoffs | ||
| 24.04. | Pfizer drafts Fernando Mendoza as new face of its 'game of inches' cancer campaign | ||
| 24.04. | Fierce Pharma Asia-Merck's PD-1xVEGF data; Zai Lab's global view; Kailera's record IPO | ||
| 24.04. | Patients less confident than ever about health choices: survey | ||
| 23.04. | Regeneron ushers in new genetic medicine era with groundbreaking gene therapy approval | ||
| 23.04. | Despite data concerns, Roche's oral SERD can still be largest product in company history: exec | ||
| 23.04. | Regeneron to unveil latest 'most favored nation' drug pricing deal with White House | ||
| 23.04. | With Dupixent driving growth, Sanofi touts 'vigorous defense' to extend US exclusivity | ||
| 23.04. | FDA citizen petition calls on agency to tighten up CRL disclosure practices | ||
| 23.04. | Roche Q1 earnings suffer blood bath, but currency headwinds aren't the only culprit | ||
| 23.04. | With trial win, Novo Nordisk eyes adolescent diabetes approval for oral semaglutide | ||
| 23.04. | More than 60% of Americans using AI tools for medical information: survey | ||
| 23.04. | Evonik to pump €80M into Slovakia production facility, add 50 jobs | ||
| 23.04. | Deerfield trots into pharma sales software space with CRM-enhancing tool | ||
| 23.04. | Merck's new AI commercial strategy 'reimagining engagement with HCPs' | ||
| 22.04. | AbbVie to establish NC production base with $1.4B investment, creating 730-plus jobs | ||
| 22.04. | Amneal seizes 'golden era' for biosims with $1.1B Kashiv buyout | ||
| 22.04. | Samsung Biologics posts massive revenue growth as labor union rally sets strike in motion | ||
| 22.04. | Merck goes with Google for AI push, striking enterprise partnership worth up to $1B | ||
| 22.04. | Novartis launches 'Sjöut for Sjögren's' campaign, teams with Carrie Ann Inaba | ||
| 21.04. | Merck amps up presence in HIV treatment market with FDA nod for novel combo pill Idvynso | ||
| 21.04. | The Oral GLP-1 Tracker: Following the launch trajectories of Lilly's Foundayo, Novo's Wegovy pill | ||
| 21.04. | Pfizer's strategy head Andrew Baum to step down following brief tenure: reports | ||
| 21.04. | AstraZeneca eyes 5th Ultomiris indication after kidney disease trial win | ||
| 21.04. | In a Merck Litespark shocker, Welireg triplet misses the mark in first-line kidney cancer |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.